Social Determinants and a Diabetes Prevention Program Tailored for African Americans
Launched by UNIVERSITY OF MISSOURI, KANSAS CITY · Mar 28, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special program designed to help African Americans who are at risk of developing diabetes due to being overweight or diagnosed with prediabetes. The goal is to improve attendance and weight loss outcomes in a Diabetes Prevention Program (DPP) by addressing cultural and economic challenges that may make it harder for people to join and stick with the program. Participants will be divided into three groups: one receiving the standard program, another getting a culturally-focused version, and a third with added support to overcome financial barriers.
To be eligible for this trial, participants must identify as Black or African American, be overweight, and either have prediabetes or be at high risk for it. Unfortunately, those with diabetes, pregnant individuals, or those who are not fluent in English cannot participate. If you join, you can expect to attend weekly classes in the evenings, where you'll learn about diet, exercise, and lifestyle changes that can help prevent diabetes. Additionally, you'll use tools like a fitness tracker and a wi-fi scale to help monitor your progress. This study aims to create a more effective program that can help reduce diabetes risk in urban African American communities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Black/African American
- • Overweight (\[BMI\> 24); and
- • Diagnosed with prediabetes OR pre-diagnosed with gestational diabetes OR high risk result on prediabetes risk test
- Exclusion Criteria:
- • Diagnosed with diabetes
- • Pregnant
- • Not fluent in English
- • Currently pregnant, planning a pregnancy in the next year, currently breastfeeding or have given birth in the last 6 months
- • Currently participating in a weight loss program
- • Currently have a medical condition that causes drastic weight loss
- • Bariatric weight loss surgery in last year
- • Cannot walk a 1-block distance without assistance and without stopping due to pain, tightness, or pressure in the chest
- • Had heart failure
- • Not willing to use a fitness tracker, wi-fi scale, and the internet
- • Not available in the evening one day each week to participate in a class
About University Of Missouri, Kansas City
The University of Missouri, Kansas City (UMKC) is a leading academic institution dedicated to advancing health and medical research through innovative clinical trials. With a robust infrastructure that fosters collaboration among multidisciplinary teams, UMKC is committed to enhancing patient care and outcomes by exploring novel therapeutic interventions. The university’s strong emphasis on research excellence and community engagement positions it at the forefront of clinical advancements, ensuring that trials are conducted with the highest ethical standards and scientific rigor. Through its extensive network of healthcare professionals and researchers, UMKC aims to translate research findings into practical applications that benefit diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Missouri, United States
Kansas City, Missouri, United States
Patients applied
Trial Officials
Jannette Y Berkley-Patton, PhD
Principal Investigator
University of Missouri-Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials